Literature DB >> 20063419

Zebrafish cardiac enhancer trap lines: new tools for in vivo studies of cardiovascular development and disease.

Kar-Lai Poon1, Michael Liebling, Igor Kondrychyn, Marta Garcia-Lecea, Vladimir Korzh.   

Abstract

Using the transposon-mediated enhancer trap (ET), we generated 18 cardiac enhancer trap (CET) transgenic zebrafish lines. They exhibit EGFP expression in defined cell types--the endocardium, myocardium, and epicardium--or in anatomical regions of the heart--the atrium, ventricle, valves, or bulbus arteriosus. Most of these expression domains are maintained into adulthood. The genomic locations of the transposon insertions were determined by thermal asymmetric interlaced polymerase chain reaction (TAIL-PCR). The expression pattern of EGFP in some CETs is unique and recapitulates expression of genes flanking the transposon insertion site. The CETs enabled us to capture the dynamics of the embryonic heart beating in vivo using fast scanning confocal microscopy coupled with image reconstruction, producing three-dimensional movies in time (4D) illustrating region-specific features of heart contraction. This collection of CET lines represents a toolbox of markers for in vivo studies of heart development, physiology, and drug screening. Copyright (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20063419     DOI: 10.1002/dvdy.22203

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  24 in total

1.  In vitro culture of epicardial cells from adult zebrafish heart on a fibrin matrix.

Authors:  Jieun Kim; Nicole Rubin; Ying Huang; Tai-Lan Tuan; Ching-Ling Lien
Journal:  Nat Protoc       Date:  2012-01-19       Impact factor: 13.491

2.  Improved Tol2-mediated enhancer trap identifies weakly expressed genes during liver and β cell development and regeneration in zebrafish.

Authors:  Yadong Zhong; Wei Huang; Jiang Du; Zekun Wang; Jianbo He; Lingfei Luo
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

Review 3.  The epicardium as a hub for heart regeneration.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

4.  AP-1 Contributes to Chromatin Accessibility to Promote Sarcomere Disassembly and Cardiomyocyte Protrusion During Zebrafish Heart Regeneration.

Authors:  Arica Beisaw; Carsten Kuenne; Stefan Guenther; Julia Dallmann; Chi-Chung Wu; Mette Bentsen; Mario Looso; Didier Y R Stainier
Journal:  Circ Res       Date:  2020-04-21       Impact factor: 17.367

5.  Zebrafish: A marvel of high-throughput biology for 21st century toxicology.

Authors:  Sean M Bugel; Robert L Tanguay; Antonio Planchart
Journal:  Curr Environ Health Rep       Date:  2014-09-07

6.  Optogenetic in vivo cell manipulation in KillerRed-expressing zebrafish transgenics.

Authors:  Cathleen Teh; Dmitry M Chudakov; Kar-Lai Poon; Ilgar Z Mamedov; Jun-Yan Sek; Konstantin Shidlovsky; Sergey Lukyanov; Vladimir Korzh
Journal:  BMC Dev Biol       Date:  2010-11-02       Impact factor: 1.978

7.  Sox9b is required for epicardium formation and plays a role in TCDD-induced heart malformation in zebrafish.

Authors:  Peter Hofsteen; Jessica Plavicki; Shaina D Johnson; Richard E Peterson; Warren Heideman
Journal:  Mol Pharmacol       Date:  2013-06-17       Impact factor: 4.436

8.  Cardiac myocyte-specific AHR activation phenocopies TCDD-induced toxicity in zebrafish.

Authors:  Kevin A Lanham; Jessica Plavicki; Richard E Peterson; Warren Heideman
Journal:  Toxicol Sci       Date:  2014-07-18       Impact factor: 4.849

9.  Dioxin inhibits zebrafish epicardium and proepicardium development.

Authors:  Jessica Plavicki; Peter Hofsteen; Richard E Peterson; Warren Heideman
Journal:  Toxicol Sci       Date:  2012-11-07       Impact factor: 4.849

10.  Retinoic acid signaling restricts the size of the first heart field within the anterior lateral plate mesoderm.

Authors:  Tiffany B Duong; Andrew Holowiecki; Joshua S Waxman
Journal:  Dev Biol       Date:  2021-02-16       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.